Page 108 | Certara

Announcement

Certara Selected by the European Medicines Agency to Provide Real World Solutions for Critical Regulatory Decisions

Princeton, N.J., March 17, 2022 -- Certara, Inc. today announced a four-year, framework service contract…

CertaraMarch 17, 2022

Blog

How to Fix Your Biggest Bioequivalence Mistakes

Bioequivalence is a commonly misunderstood term within biopharmaceutics. For starters, bioequivalence is a technical term…

CertaraMarch 16, 2022

Conference

ASCPT 2025 Annual Meeting

May 28-31, 2025 - Washington, DC

CertaraMarch 7, 2022

Blog

New PMDA Validation Rules 3.0 Explained

In this blog, we explore what you need to know about the update to the…

CertaraMarch 2, 2022

Blog

Experts Unravel the Top 5 Myths Related to Bioequivalence

Bioequivalence enables bridging safety and effectiveness of oral pharmaceutical dosage forms using pharmacokinetics. The concepts…

CertaraFebruary 18, 2022

Press Coverage

The Challenging Road to Developing an Integrated Platform for Drug Discovery and Precision Medicine Using the Power of Pharmacometrics

We have often seen Dr. Hwi-yeol (Thomas) Yun, Associate Professor/Adjunct Professor at the College of…

CertaraFebruary 7, 2022

Blog

What is the FDA’s Project Optimus & How Will it Affect Oncology Drug Development?

Project Optimus is an initiative proposed by the U.S. Food and Drug Administration’s Oncology Center…

CertaraFebruary 2, 2022

On-Demand Webinar

Improved Workflow and Expanded functionality of RsNLME v1.1

R Speaks NLME (RsNLME) is a collection of R packages and companion RShiny apps that…

CertaraJanuary 31, 2022

Blog

Choosing an eCTD Submissions Vendor: Your Complete Checklist

September 3, 2025 Selecting the right electronic submission vendor for regulatory submissions to health authorities…

CertaraJanuary 28, 2022

Blog

Don’t Forget About Safety! How to Assess Drug Candidate Safety in Early Clinical Development

This blog will reflect on 3 things drug developers should pay attention to regarding safety…

CertaraJanuary 24, 2022

Certara Selected by the European Medicines Agency to Provide Real World Solutions for Critical Regulatory Decisions

How to Fix Your Biggest Bioequivalence Mistakes

ASCPT 2025 Annual Meeting

New PMDA Validation Rules 3.0 Explained

Experts Unravel the Top 5 Myths Related to Bioequivalence

The Challenging Road to Developing an Integrated Platform for Drug Discovery and Precision Medicine Using the Power of Pharmacometrics

What is the FDA’s Project Optimus & How Will it Affect Oncology Drug Development?

Improved Workflow and Expanded functionality of RsNLME v1.1

Choosing an eCTD Submissions Vendor: Your Complete Checklist

Don’t Forget About Safety! How to Assess Drug Candidate Safety in Early Clinical Development

Newsletter sign up

Quick links

Solutions

Contact